Toggle navigation
About
Abstract
Editorial Board
Subscription & Newsletter
Contact
Issues
This issue
17-1
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
17-1
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #28047
advertisement
Landers J
5
Showing records 1 to 5 |
Display all abstracts from
Landers J
61436
Occurrence of CYP1B1 Mutations in Juvenile Open-Angle Glaucoma With Advanced Visual Field Loss
Souzeau E
JAMA ophthalmology
2015; 133: 826-833
61614
Ibopamine challenge testing differentiates glaucoma suspect, stable glaucoma and progressive glaucoma cases
Landers J; Ullrich K
Clinical and Experimental Ophthalmology
2015; 43: 808-814
61436
Occurrence of CYP1B1 Mutations in Juvenile Open-Angle Glaucoma With Advanced Visual Field Loss
Hayes M
JAMA ophthalmology
2015; 133: 826-833
61614
Ibopamine challenge testing differentiates glaucoma suspect, stable glaucoma and progressive glaucoma cases
Craig JE
Clinical and Experimental Ophthalmology
2015; 43: 808-814
61436
Occurrence of CYP1B1 Mutations in Juvenile Open-Angle Glaucoma With Advanced Visual Field Loss
Zhou T; Siggs OM; Ridge B; Awadalla MS; Smith JE; Ruddle JB; Elder JE; Mackey DA; Hewitt AW; Healey PR; Goldberg I; Morgan WH; Landers J; Dubowsky A; Burdon KP; Craig JE
JAMA ophthalmology
2015; 133: 826-833
Issue
17-1
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept